Press releases
These press releases are intended for journalists and analysts/investors.
-
GSK invests to support female technology entrepreneurs
GSK Australia announced today that it will support BlueChilli’s ‘SheStarts’
-
GSK Consumer Healthcare to close Ermington manufacturing site in 2020
All entitlements are protected for the 223 employees whose jobs are affected, and the company will work through the next four years
-
Bexsero (Meningococcal B) vaccine availability (1)
Recently there has been a global increase in demand for Bexsero® (meningococcal B) vaccine which is reflected in Australia as well
-
GSK founding partner for Victorian Medicines Manufacturing Innovation Centre
GSK Australia today announced its financial and in-kind support for the Medicine Manufacturing Innovation Centre (MMIC)
-
Whooping cough vaccines availability update
BOOSTRIX®-IPV is a combined diphtheria-tetanus-acellular pertussis and polio virus vaccine used as a booster in adults and children 4-years
-
Anne Belcher to succeed Geoff McDonald as GSK Australia general manager
GSK Australia announced today that Mrs Anne Belcher will succeed Mr Geoff McDonald as general manager of GSK Pharmaceuticals in Australia
-
GSK publishes transfer of value report
Medicines Australia transparency improves understanding of the relationship between industry and healthcare professionals
-
Experts urge hay fever sufferers to get symptoms under control
Leading Australian lifestyle and media commentator Shelly Horton has sprung into action today launching a new health campaign urging people
-
Global survey finds parents need to short-circuit their own anxiety to better manage their child’s illness
Global survey finds parents need to short-circuit their own anxiety to better manage their child’s illness
-
A shot in the arm for a shot at gold
The Australian Women’s Football team received travel vaccinations free of charge as part of an agreement between GSK and the Australian
-
Bactroban (mupirocin) 2% Ointment supply
Following manufacturing issues, supply of Bactroban (mupirocin) 2% Ointment for the topical treatment of mild impetigo
-
Easier access to medicines for men with enlarged prostates following medicine reimbursement changes
Australian men with an enlarged prostate are set to benefit from changes to the Pharmaceutical Benefits Scheme (PBS) which now allows
-
Supply of Zovirax Ophthalmic Ointment (aciclovir 3%) resumes
Resumed supply of Zovirax Ophthalmic Ointment confirmed following a global supply shortage
-
Product Recall - Children's Panadol
Providing quality products and consumer safety are always our top priority and we want to ensure that consumers only have access
-
GSK Australia Reports 2015 results to ASIC
GlaxoSmithKline (GSK) Australia has reported its 2015 results to the Australian Securities and Investment Commission (ASIC)
-
Supply of Bactroban products
GSK advises of a temporary disruption to the supply of Bactroban Cream (mupirocin calcium cream, 2% w/w), Bactroban Ointment and Bactroban
-
GSK discloses payments to Australian healthcare professionals in 2015
In 2015, GSK Australia made payments totalling $3.6 million to healthcare professionals (HCPs) and health-related organisations (HCOs)
-
GSK supports National Immunisation Program (NIP) with additional whooping cough protection via an 18-month dose on the NIP
GSK Australia is proud to be partnering with the Australian Government to re-introduce a diphtheria, tetanus, acellular pertussis (DTPa)
-
Whooping cough vaccines update
Additional whooping cough booster at 18-months on the NIP
-
Australia leads the world in body pain blues
New research shows that 97 percent of Australians suffer from body aches, with a massive two thirds (68%) experiencing it at least weekly
